Back to ZNTL

GOLDMAN SACHS GROUP INC → ZNTL

GOLDMAN SACHS GROUP INC ZNTL Position History

Zentalis Pharmaceuticals, Inc. • Healthcare

Quarters held
14
Latest value
$172K
Q3 2026
Peak value
$1.5M
First seen
Q2 2025

Dollar value over time

Show data table
PeriodPosition value
Q2 2025$933K
Q2 2025$67K
Q3 2025$462K
Q3 2025$59K
Q4 2025$52K
Q4 2025$108K
Q4 2025$108K
Q4 2025$52K
Q1 2026$963K
Q1 2026$120K
Q2 2026$1.5M
Q2 2026$337K
Q3 2026$335K
Q3 2026$172K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$172K62.0K——
Q3 2026$335K120.9K——
Q2 2026$337K69.6K——
Q2 2026$1.5M303.0K——
Q1 2026$120K51.2K——
Q1 2026$963K411.5K——
Q4 2025$52K38.5K——
Q4 2025$108K79.7K——
Q4 2025$108K79.7K——
Q4 2025$52K38.5K——
Q3 2025$59K39.4K——
Q3 2025$462K305.8K——
Q2 2025$67K57.3K——
Q2 2025$933K804.4K——

Other funds holding ZNTL

$270.2M
$250.2M
$186.7M
$164.2M
$139.5M
$133.3M
$133.1M
$130.5M

Other GOLDMAN SACHS GROUP INC positions

NVDA

NVIDIA CORPORATION

$37B
AAPL

APPLE INC

$31.7B
NVDA

NVIDIA CORPORATION

$31.3B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.9B
NVDA

NVIDIA CORPORATION

$27.3B
AAPL

APPLE INC

$26.9B
NVDA

NVIDIA CORPORATION

$26.5B